Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Narrative (Details)

v3.22.2.2
Revenue Recognition - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
unit
Jun. 30, 2021
USD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jul. 16, 2021
shares
Deferred Revenue Arrangement [Line Items]                      
Current portion of contract assets $ 3,070         $ 3,070     $ 1,459    
Contract assets, noncurrent 3,159         3,159     3,418    
Revenue recognized from prior year deferred revenue balance 2,200     $ 600   4,658 $ 1,800        
Deferred asset related to commissions 5,700         5,700     5,400    
Amortized commissions 900     500   1,200 600        
General and administrative $ 9,612 $ 10,817 $ 7,535 $ 1,471 $ 3,052 $ 20,429 $ 4,523 $ 12,058 $ 19,869 $ 5,530  
Give Evolv LLC                      
Deferred Revenue Arrangement [Line Items]                      
Initial contribution of common shares (in shares) | shares                     517,500
Number of Evolv Express units donated | unit           3          
General and administrative           $ 200